Over the past decade we’ve seen rapid growth in value-based care programs. While some have succeeded in improving quality or ...

The 2024 Trends Shaping the Health Economy report gave a past, present, and future look at diabetes care in the US and the ...

Value-based agreements come with risks and benefits, but a health system’s existing facilities and initiatives can help support the goals associated with them, JT Lew, PharmD, MBA, a managed care ...

Javed Butler, MD, MPH, MBA, discusses the additional benefits of combining finerenone with sodium-glucose cotransporter-2 ...

Javed Butler, MD, MPH, MBA, discusses the data from European Society of Cardiology Congress 2024 on β-blocker use in patients ...

In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals ...

Clyde Yancy, MD, MSc, FHFSA, professor, chief of cardiology, and vice dean of diversity and inclusion at Northwestern ...

A French study found that follitropin alfa, a biosimilar fertility drug, is more cost-effective compared with its originator, ...

Despite reductions in deaths from cancer and cardiovascular diseases, increased mortality from assaults, accidents, and the ...

Systemic racism, including the practice of redlining, has had an enduring effect on health outcomes in people living with HIV ...

Average Medicare drug premiums for older Americans will drop next year for those enrolled in traditional Medicare plans or ...

Survey reveals gaps in vaccination intentions for flu, COVID-19, respiratory syncytial virus, and pneumococcal disease.